BLAM
Bourne Lent Asset Management’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Hold |
972,255
| – | – | 0.47% | 30 |
|
|
2025
Q1 | $1.15M | Buy |
972,255
+28,500
| +3% | +$33.6K | 0.49% | 29 |
|
|
2024
Q4 | $1.73M | Sell |
943,755
-10,840
| -1% | -$19.8K | 0.66% | 26 |
|
|
2024
Q3 | $1.62M | Buy |
954,595
+3,200
| +0.3% | +$5.44K | 0.62% | 27 |
|
|
2024
Q2 | $1.3M | Buy |
951,395
+296,980
| +45% | +$407K | 0.5% | 29 |
|
|
2024
Q1 | $2.45M | Buy |
654,415
+62,200
| +11% | +$233K | 0.99% | 19 |
|
|
2023
Q4 | $5.81M | Buy |
592,215
+17,865
| +3% | +$175K | 2.36% | 12 |
|
|
2023
Q3 | $4.8M | Sell |
574,350
-5,650
| -1% | -$47.2K | 2.11% | 13 |
|
|
2023
Q2 | $7.71M | Sell |
580,000
-11,450
| -2% | -$152K | 2.69% | 11 |
|
|
2023
Q1 | $6.85M | Hold |
591,450
| – | – | 2.59% | 11 |
|
|
2022
Q4 | $4.84M | Buy |
591,450
+7,300
| +1% | +$59.7K | 2.07% | 13 |
|
|
2022
Q3 | $3.39M | Buy |
584,150
+25,285
| +5% | +$147K | 1.47% | 16 |
|
|
2022
Q2 | $2.47M | Buy |
558,865
+2,000
| +0.4% | +$8.84K | 0.98% | 20 |
|
|
2022
Q1 | $5.07M | Buy |
556,865
+1,115
| +0.2% | +$10.1K | 1.59% | 15 |
|
|
2021
Q4 | $11.4M | Buy |
555,750
+2,900
| +0.5% | +$59.3K | 3.04% | 11 |
|
|
2021
Q3 | $14.1M | Buy |
552,850
+4,000
| +0.7% | +$102K | 4.05% | 9 |
|
|
2021
Q2 | $19.2M | Buy |
548,850
+12,050
| +2% | +$421K | 5.39% | 7 |
|
|
2021
Q1 | $17.9M | Buy |
536,800
+1,850
| +0.3% | +$61.6K | 5.71% | 6 |
|
|
2020
Q4 | $13.9M | Sell |
534,950
-21,000
| -4% | -$545K | 4.57% | 7 |
|
|
2020
Q3 | $5.49M | Sell |
555,950
-450
| -0.1% | -$4.44K | 2.11% | 12 |
|
|
2020
Q2 | $1.92M | Hold |
556,400
| – | – | 0.83% | 18 |
|
|
2020
Q1 | $1.7M | Buy |
556,400
+114,750
| +26% | +$351K | 0.91% | 19 |
|
|
2019
Q4 | $2.27M | Hold |
441,650
| – | – | 1.07% | 18 |
|
|
2019
Q3 | $2.28M | Buy |
441,650
+106,000
| +32% | +$547K | 1.09% | 16 |
|
|
2019
Q2 | $2.03M | Hold |
335,650
| – | – | 0.97% | 18 |
|
|
2019
Q1 | $2.43M | Hold |
335,650
| – | – | 1.2% | 15 |
|
|
2018
Q4 | $2.48M | Buy |
335,650
+8,500
| +3% | +$62.9K | 1.47% | 15 |
|
|
2018
Q3 | $1.77M | Hold |
327,150
| – | – | 0.84% | 19 |
|
|
2018
Q2 | $1.16M | Buy |
327,150
+9,498
| +3% | +$33.7K | 0.61% | 24 |
|
|
2018
Q1 | $651K | Buy |
317,652
+26,200
| +9% | +$53.7K | 0.35% | 31 |
|
|
2017
Q4 | $769K | Buy |
291,452
+89,002
| +44% | +$235K | 0.41% | 31 |
|
|
2017
Q3 | $1.06M | Buy |
202,450
+4,000
| +2% | +$21K | 0.55% | 25 |
|
|
2017
Q2 | $706K | Sell |
198,450
-4,500
| -2% | -$16K | 0.39% | 30 |
|
|
2017
Q1 | $1.05M | Hold |
202,950
| – | – | 0.57% | 25 |
|
|
2016
Q4 | $771K | Buy |
202,950
+22,400
| +12% | +$85.1K | 0.46% | 28 |
|
|
2016
Q3 | $1.62M | Buy |
180,550
+4,200
| +2% | +$37.6K | 1.19% | 15 |
|
|
2016
Q2 | $1.24M | Buy |
176,350
+13,000
| +8% | +$91.5K | 0.98% | 19 |
|
|
2016
Q1 | $1.39M | Buy |
163,350
+18,575
| +13% | +$158K | 1.11% | 18 |
|
|
2015
Q4 | $1.9M | Sell |
144,775
-10,000
| -6% | -$131K | 1.44% | 12 |
|
|
2015
Q3 | $566K | Buy |
154,775
+2,200
| +1% | +$8.05K | 0.46% | 29 |
|
|
2015
Q2 | $879K | Buy |
152,575
+5,000
| +3% | +$28.8K | 0.69% | 24 |
|
|
2015
Q1 | $862K | Buy |
+147,575
| New | +$862K | 0.65% | 24 |
|